PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FA3CZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $54,033
Award facts
- Contract value 100% obligated
- $54,033.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain awarded a $54,033 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 29, 2025, with completion targeted for December 30, 2025. This non-set-aside award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical supply vendor that delivers a comprehensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems.
As a prime vendor under the DLA's pharmaceutical support framework, AmerisourceBergen supplies brand-name and generic medications, vaccines, specialized medical devices, and healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order represents one of numerous competitively awarded transactions under the company's master IDC vehicle, demonstrating AmerisourceBergen's capability to fulfill federal medical procurement requirements. The DLA is implementing a strategic approach to pharmaceutical vendor management through its Pharmaceutical Prime Vendor Global Program Generation V initiative, which plans multiple regional contract awards to ensure robust supply chain capacity for military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2D826FA3CZ?
SPE2D826FA3CZ was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on December 29, 2025.
How much is contract SPE2D826FA3CZ worth?
The government has obligated $54,033 on SPE2D826FA3CZ.
Is contract SPE2D826FA3CZ an order under another contract?
Yes. SPE2D826FA3CZ is a delivery order under SPE2DX22D0049, an indefinite delivery contract.
Was contract SPE2D826FA3CZ competed?
The extent of competition for SPE2D826FA3CZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award